More info
Alli 60 mg hard capsules
For its composition, contraindications, usage, International Pharmacy Please check below details of its prospectus, downloadable. Follow the instructions exactly Allli management Capsules contained in the product insert.
Prospect in Spanish: user information in the prospectus.
Read this leaflet carefully before you start taking this medicine because it contains important information for you.
In this leaflet:
- What is Alli capsules and what is it used? - Risk of being overweight - How does Alli
- Things to know before you start taking Alli? - Do not take Alli - Warnings and Precautions - Using Alli with other medicines - Taking alli with food and drink - Pregnancy and breast-feeding - Driving and using machines
- Taking Alli? - Preparing to lose weight - Choose your start date - Decide on your weight loss goal - Set your calorie and fat targets. - Taking alli - Adults 18 and over - How long should I take Alli? - Alli If you take more than you should - If you forget to take Alli
- Possible side effects of Alli capsules - Serious side effects - Very common side effects - Common side effects - Side effects observed in blood tests - Learn to control the effects of diet-related treatment
- Conservation Alli capsules.
Contents of the pack and other information capsulas- composition Alli Alli - looks like and contents of the pack -
Authorization holder responsible for marketing and manufacturing - More useful information
- Follow the instructions of drug administration in this leaflet or as your doctor or pharmacist. Keep this leaflet, as you may need to read it again.
- If you need more information or advice, ask your doctor or pharmacist.
- If you get any side effects, contact your doctor or pharmacist, even if it comes to side effects not listed in this leaflet. See Section 4.
- If you do not lose weight after taking alli for 12 weeks, ask your doctor or pharmacist. You may need to stop taking Alli.
For any information about this medicine, please contact the local representative of the holder of the marketing authorization.
You can also visit the specific alli website in your country for more information on weight loss program there.
For any information about this medicine, please contact the local representative of the holder of the marketing authorization.
You can also visit the website of Alli specific to your country for more information on weight loss program there.
GlaxoSmithKline Consumer Healthcare Deutschland GmbH & Co. KG, Tel: 0049 (0) 180 3 63462554 www.alliprogramm.de
GlaxoSmithKline Consumer Healthcare Norge Phone: + 47 22 70 22 01 dk.info@gsk.com www.alliplan.no
Österreich GlaxoSmithKline Consumer Healthcare GmbH & Co. KG, Tel: 0049 (0) 180 3 63462554 www.alliprogramm.at
Spain GlaxoSmithKline Consumer Healthcare, S.A. Tel: + 34 902 014 400 www.alli.com.es
GlaxoSmithKline Consumer Healthcare Portugal - Produtos para a Saúde and Health, Lda Tel: 800201343 LIS.FI-CH@gsk.com www.alli.pt.
France GlaxoSmithKline Santé Grand Public Tél .: + 33 (0) 1 39 17 80 00 www.alliprogramme.fr
GlaxoSmithKline Consumer Healthcare Italia S.p.A. Tel: + 39 02 38062020 www.alli.it
GlaxoSmithKline Consumer Healthcare United Kingdom Tel: + 44 (0) 800 171 2014 (Freephone) customer.relations@gsk.com www.alli.co.uk
Date of last revision of this leaflet:
Detailed information on this product is available on the website of the European Medicines Agency http://www.ema.europa.eu
Follow us